Dysautonomia in RFC1-related disorder: Clinical and neurophysiological evaluation

Autor(es)

Schmitt, Gabriel da Silva ; de Lima, Fabricio Diniz ; Matos, Paula Camila A. A. P. ; Martinez, Alberto R. M. ; Gonzalez-Salazar, Carelis ; Nucci, Anamarli ; Marques Jr, Wilson ; Barsottini, Orlando Graziani P. ; Pedroso, Jose Luiz ; Franca Jr, Marcondes Cavalcante

• Tipo de documento: Artigo Científico
• Fonte: CLINICAL NEUROPHYSIOLOGY; v. 142, p. 7-pg., 2022-08-12.

Resumo

Objective: To characterize and quantify autonomic involvement in patients with RFC1-related disorder of adult-onset cerebellar ataxia and idiopathic sensory neuropathy. Methods: We enrolled 16 subjects with biallelic RFC1 (AAGGG)n expansions and 16 age and sex-matched healthy controls that underwent comprehensive clinical and neurophysiological evaluation. Scales for Outcomes in Parkinson's Disease Autonomic Dysfunction (SCOPA-AUT) score was used to assess autonomic symptoms. Electrophysiological testing included assessment of heart rate variability and quantitative sudomotor axon reflex test (QSART). Between-group comparisons were assessed using nonparametric tests. Results: In the patient group, there were 9 men/7 women and the median age was 60.5 years. SCOPA-AUT scores were significantly higher in the RFC1 group compared to controls (22 vs 10, p < 0.001). Half of patients had cardiac autonomic neuropathy. In neurophysiology, there was resting tachycardia combined with abnormal responses during Valsalva maneuver and deep breathing among patients. QSART responses were also significantly reduced in the RFC1 group, especially in the lower limbs. Conclusions: Autonomic dysfunction is frequent, clinically relevant and involves multiple domains in RFC1-related disorder. Patients have both sympathetic and parasympathetic involvement. From a topographical perspective, this condition is characterized by a small fiber autonomic axonopathy. Significance: Dysautonomia is frequent, severe and related to peripheral damage in RFC1-related disorder. (c) 2022 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved. (AU)

• Processo FAPESP: 13/07559-3 - Instituto Brasileiro de Neurociência e Neurotecnologia - BRAINN
• Beneficiário: Fernando Cendes
• Modalidade de apoio: Auxílio à Pesquisa - Centros de Pesquisa, Inovação e Difusão - CEPIDs